News & Videos - LIFEMD INC. - English

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 17, 2023, to holders of record at the close of business on July 7, 2023. About LifeMD LifeMD™ is a 50-state...

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the formal launch of its GLP-1 weight management program following a successful pilot earlier this year. The formal launch of LifeMD’s weight management program coincides with bespoke platform enhancements built to support and personalize patient weight loss journeys, including treatment with prescription GLP-1 medications. LifeMD now offers a complete...

Record first quarter 2023 consolidated revenue of $33.1 million, up 14% from the same year-ago period. Record Adjusted EPS of $0.06 per share, up 126% versus the prior year. Record Adjusted EBITDA of $2.0 million, up 126% versus the prior year. Executed debt financing transaction with Avenue Capital, providing up to $40 million of total capital and strengthening LifeMD’s long-term capital position. Re-affirm Full Year 2023 revenue guidance of $140 to $150 million and consolidated Adjusted...

NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced that it has entered into an agreement to be the exclusive telehealth provider for HealthWarehouse.com, Inc. (OTC: HEWA). The partnership between the two companies will enable HealthWarehouse.com to offer virtual treatment to over one million existing patients and make available real-time consultations to potential new patients purchasing pharmacy products...

NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market open on Friday, May 12, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30am Eastern Time. Conference Call & Webcast Details: Date: Friday, May 12 th Time: 8:30am ET Toll...

NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced the launch of new membership plans that enable immediate access to best-in-class virtual care. LifeMD’s new plans, powered by innovative features and enhancements to its proprietary app, expand care and provide patients with the most flexibility when seeking virtual treatment. Effective immediately, all consumers can download LifeMD’s free mobile app...

NEW YORK, March 28, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 17, 2023, to holders of record at the close of business on April 7, 2023. About LifeMD LifeMD™ is a 50-state...

Achieved consolidated Adjusted EBITDA profitability for first-time in LifeMD history Full Year 2022 consolidated revenue of $119.0 million, up 28% from the same year-ago period. Fourth quarter 2022 consolidated revenue of $28.1 million up 3% from the same year-ago period. This figure was impacted by a $2.9 million deferral of telehealth shipments. Adjusted EPS of $0.02, 107% improvement versus the prior year. Subsequent to year end, executed debt financing transaction with Avenue Capital,...

NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that the Company closed on a new senior secured credit facility with Avenue Capital. The credit agreement, which matures on October 1, 2026, provides up to $40 million in total term loan capital including a first tranche of $15 million funded at closing, a second tranche of $5 million of committed capital and an additional accordion option to upsize the credit...

NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Wednesday, March 22, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Conference Call & Webcast Details: Date: Wednesday,...

NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Dr. Joan LaRovere to its Board of Directors. With Dr. LaRovere’s appointment, LifeMD’s Board will comprise nine directors, seven of whom are independent. “We are pleased to welcome Dr. LaRovere to the LifeMD Board,” said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. “Dr. LaRovere’s leadership and clinical...

NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Jessica Friedeman as Chief Marketing Officer. Friedeman succeeds Stefan Galluppi, who continues as LifeMD’s Chief Innovation Officer. Friedeman brings nearly twenty years’ experience engaging and retaining patients, with a proven track record of increasing efficiency and revenue by executing go-to-market product strategy for...

NEW YORK, Dec. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on January 17, 2023, to holders of record at the close of business on January 6, 2023. About LifeMD LifeMD™ is a 50-state...